Table 1 The 40 top differentially expressed genes (DEGs) in non-polyp nasal epithelial mucosa from patients with CRSwNP versus polyp mucosa in the same patient.

From: Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal polyps

RNA

baseMean

log2FoldChange

lfcSE

stat

p value

padj

CCL18

335.54

6.28

0.78

 − 8.01

1.12 × 10−15

3.67 × 10−11

CLEC4G

75.28

6.11

0.78

 − 7.80

6.06 × 10−15

9.93 × 10−11

SLC9A3

460.64

3.96

0.52

 − 7.57

3.83 × 10−14

4.04 × 10−10

CCL13

222.07

5.29

0.70

 − 7.53

4.94 × 10−14

4.04 × 10−10

SLC9A3-AS1

810.12

1.23

0.16

 − 7.50

6.23 × 10−14

4.09 × 10−10

OXTR

385.95

3.55

0.48

 − 7.47

7.75 × 10−14

4.23 × 10−10

C1QB

533.27

2.61

0.35

 − 7.39

1.46 × 10−13

6.82 × 10−10

CDH26

1632.59

3.00

0.41

 − 7.37

1.77 × 10−13

7.23 × 10−10

F13A1

2594.99

3.21

0.45

 − 7.13

9.73 × 10−13

3.33 × 10−09

MARCO

186.31

5.52

0.77

 − 7.13

1.02 × 10−12

3.33 × 10−09

CFI

786.72

1.71

0.25

 − 6.92

4.58 × 10−12

1.37 × 10−08

PRH2

220.91

 − 5.71

0.83

6.87

6.58 × 10−12

1.80 × 10−08

RHAG

24.29

 − 5.16

0.75

6.85

7.36 × 10−12

1.85 × 10−08

HES4

103.20

1.04

0.15

 − 6.82

8.80 × 10−12

2.06 × 10−08

SLC37A2

1936.03

 − 2.31

0.34

6.81

1.00 × 10−11

2.19 × 10−08

CLC

251.95

5.31

0.78

 − 6.76

1.39 × 10−11

2.84 × 10−08

ANAPC5

3935.01

 − 0.43

0.06

6.75

1.47 × 10−11

2.84 × 10−08

CEBPE

23.46

4.79

0.72

 − 6.70

2.12 × 10−11

3.87 × 10−08

GPAM

529.09

 − 0.46

0.07

6.64

3.23 × 10−11

5.57 × 10−08

LACRT

256.48

 − 4.67

0.71

6.61

3.73 × 10−11

6.12 × 10−08

DOK1

171.50

1.37

0.21

 − 6.56

5.51 × 10−11

8.60 × 10−08

PKDCC

1217.18

 − 2.93

0.45

6.52

7.15 × 10−11

1.06 × 10−07

MS4A4A

223.73

2.56

0.39

 − 6.51

7.61 × 10−11

1.08 × 10−07

KCTD17

80.18

1.15

0.18

 − 6.49

8.58 × 10−11

1.17 × 10−07

ST6GALNAC2

161.85

0.99

0.15

 − 6.45

1.10 × 10−10

1.44 × 10−07

HOXB-AS1

25.15

2.09

0.32

 − 6.45

1.15 × 10−10

1.44 × 10−07

SSBP4

441.60

0.98

0.15

 − 6.43

1.25 × 10−10

1.51 × 10−07

CEP72

214.53

1.28

0.20

 − 6.38

1.72 × 10−10

2.01 × 10−07

HK3

147.80

3.20

0.50

 − 6.37

1.85 × 10−10

2.10 × 10−07

PAFAH1B3

89.57

0.69

0.11

 − 6.34

2.32 × 10−10

2.48 × 10−07

ADAP1

46.78

1.29

0.20

 − 6.34

2.35 × 10−10

2.48 × 10−07

SYT17

148.54

1.47

0.23

 − 6.31

2.84 × 10−10

2.80 × 10−07

GABRP

2266.10

2.16

0.34

 − 6.31

2.88 × 10−10

2.80 × 10−07

SIGLEC8

39.31

3.00

0.48

 − 6.30

2.90 × 10−10

2.80 × 10−07

SUCNR1

68.04

3.64

0.58

 − 6.30

3.05 × 10−10

2.86 × 10−07

C20orf197

29.59

1.88

0.30

 − 6.29

3.21 × 10−10

2.92 × 10−07

DNAJC25

226.50

 − 0.48

0.08

6.28

3.46 × 10−10

3.07 × 10−07

SCGB2A2

369.54

 − 4.00

0.64

6.26

3.76 × 10−10

3.23 × 10−07

PDLIM4

296.85

0.78

0.12

 − 6.26

3.91 × 10−10

3.23 × 10−07

FOLR2

139.85

2.48

0.39

6.25

3.94 × 10−10

3.23 × 10−07

  1. The mRNA levels (baseMean) of expressed genes and p-values adjusted using the Benjamini–Hochberg method.
  2. BaseMean mean RNA count, lfcSE log2 Fold Change Standard Error, stat Wald statistic Z-score, padj p-value adjusted.